Who should receive EGFR tyrosine-kinase inhibitors? Journal Article

  

Authors:	Yu, H. A.; Riely, G. J.
Article Title:	Who should receive EGFR tyrosine-kinase inhibitors?
Journal Title:	Lancet Oncology
Volume:	13
Issue:	11
ISSN:	1470-2045
Publisher:	Elsevier Science, Inc.
Date Published:	2012-11-01
Start Page:	1074
End Page:	1076
Language:	English
DOI:	10.1016/s1470-2045(12)70434-5
PROVIDER:	scopus
PUBMED:	23078959
DOI/URL:	http://release-www.scopus.com/inward/record.url?eid=2-s2.0-84868204421&partnerID=40&md5=aa95a18f26f337e23d4ab81fb73c3e6e
Notes:	--- - "Export Date: 3 December 2012" - "CODEN: LOANB" - "Source: Scopus"

https://synapse.mskcc.org/synapse/works/has_related_data_chk/36797